.jpg?format=webp&width=780)
Glioblastoma (GBM) is adults' most lethal primary brain tumor and harbors a subpopulation of glioma stem cells (GSCs). Enhancer of Zeste Homolog 2 (EZH2), a histone lysine methyltransferase, is deeply involved in GSC's stemness maintenance. Overexpression of HP1BP3 enhances the proliferation, self-renewal and temozolomide (TMZ) resistance of GBM cells. Importantly, inhibition of WNT7B autocrine via LGK974 effectively reverses the TMZ resistance. The study clarifies a new oncogenic mechanism of EZH2 that interacts with HP1BP3 and epigenetically activates WNT7B, thereby promoting TMZ resistance in GSCs. The results provide a rationale for targeting the WNT/β-catenin pathway as a promising strategy to overcome TMZ resistance in GSCs.
Like
Save
Share